MiR-93 induces HCC cell proliferation and invasion by activating c-Met/PI3K/Akt signaling pathways and targeting PDCD4 and TIMP2 (Ohta et al., 2015; Ji et al., 2017; Xue et al., 2018). The gene discussed is MET; the disease is hepatocellular carcinoma.